Bunitrolol is a beta-adrenergic antagonist used in the clinical management of coronary heart disease to improve cardiac performance through beta-blockade. This category contains essential tools for pharmaceutical… Read more
Bunitrolol is a beta-adrenergic antagonist used in the clinical management of coronary heart disease to improve cardiac performance through beta-blockade. This category contains essential tools for pharmaceutical analysis, including the active pharmaceutical ingredient, related impurities like N-nitroso bunitrolol, and the stable isotope labelled compound bunitrolol-D5. These products are vital for rigorous quality control, impurity profiling, and method validation in laboratory environments. Stable isotope labelled compounds, in particular, serve as precise internal standards for mass spectrometry-based pharmacokinetic studies, ensuring accuracy in quantifying drug levels. By utilizing these certified reference standards, researchers and analytical chemists can reliably monitor degradation products and verify the purity of formulations throughout the development and manufacturing processes of this cardiovascular medication.